Intrinsic Value of S&P & Nasdaq Contact Us

Sintx Technologies, Inc. SINT NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
37/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Sintx Technologies, Inc. (SINT) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 1 Buy, 1 Hold.

Analysts estimate Earnings Per Share (EPS) of $-14.80 and revenue of $0.00B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-1.49 vs est $-14.80 (beat +89.9%). 2025: actual $-6.16 vs est $-6.06 (missed -1.7%). Analyst accuracy: 0%.

SINT Analyst Ratings

Buy
2
Ratings
1 Buy
1 Hold
Based on 2 analysts giving stock ratings to Sintx Technologies, Inc. in the past 3 months
Rating breakdown
Buy
1 50%
Hold
1 50%
50%
Buy
1 analysts
50%
Hold
1 analysts
0%
Sell
0 analysts

EPS Estimates — SINT

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$1.49 vs Est –$14.80 ▲ 893.3% off
2025 Actual –$6.16 vs Est –$6.06 ▼ 1.6% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — SINT

96%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $0.003B vs Est $0.003B ▼ 0.0% off
2025 Actual $0.001B vs Est $0.001B ▼ 7.9% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message